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Background: Children are particularly vulnerable to the psychological effects of the COVID-19 pandemic. The disruption 
in daily life has impacted children significantly. Moreover, the increased worrying associated with the probability of getting 
infected or becoming seriously unwell due to infection can potentially precipitate anxiety disorders among children. 
Objective: This study aimed to determine rates of elevated anxiety symptoms in children with COVID-19 infection. It also 
explored whether there were any differences in terms of age, gender, and residency status. 
Method: A cross-sectional, questionnaire-based study with 88 participants (children aged 7-13 years, 54.5% males, 45.5% 
females) from two institutional quarantine centers. The Spence Children’s Anxiety Scale and its validated Arabic version (self-
reported questionnaires) were used to measure anxiety symptoms. 
Results: 36.3% children reported elevated anxiety symptoms. A lower rate of 32.8% was reported in younger children (7-11 
years) compared to 45.8% in older children (12 and 13 years). 70.4% and 57.9% children reported physical injury fears and 
separation anxiety respectively. A higher prevalence of overall anxiety was reported in children from expatriate families (40.6%) 
compared to native children (25%). The difference in the mean scores between the expatriate and native group of children 
was found statistically significant for obsessive-compulsive symptoms. 
Conclusions: The prevalence of elevated anxiety symptoms among children in quarantine with COVID-19 infection can be 
much higher than that reported in the general population. Older children can have elevated anxiety symptoms more commonly 
than their younger counterparts can. Expatriate children are likely to be more vulnerable to the psychological impact of the 
pandemic compared to children from local families. Our results suggest the crucial need of focusing on the psychological 
impact of COVID-19 pandemic on children. The prioritization and effective management of the mental health needs of 
children should be a vital component of the overall, global response to the pandemic. 
 




Worrying is considered a normal and adaptive 
component of emotional development in children.  
By the time they reach primary school, up to 70% of 
children report some kind of worrying (1). However, 
worrying can become pathological when excessive 
and persistent, and when it interferes with the child’s 
functioning (2). Such pathological worrying in 
children usually exists as part of an anxiety or mood 
disorder (3). Anxiety disorders are the most common 
mental disorders with onset during childhood, with a 
prevalence that ranges from 10 to 30 percent (4-6). 
The worldwide prevalence of any anxiety disorder 
among children according to the Diagnostic and 
Statistical Manual (DSM) and International Statistical 
Classification of Diseases and Related Health 
Problems (ICD) is around 6.5% (7).  





Although the median age of onset of anxiety 
disorders is thought to be around 11 years (8), 
specific anxiety disorders may have their onset at 
different developmental stages. Separation anxiety is 
more common during the preschool or early school-
age years; specific phobias in the school-age years; 
social anxiety in the later school-age and early 
adolescent years; and generalized anxiety, panic, and 
agoraphobia in the later adolescent years (9) Anxiety 
disorders during childhood are associated with 
impaired socio-occupational functioning and render 
an individual vulnerable to experiencing recurring 
anxiety and other mental health disorders in later life 
(10, 11). Children with anxiety disorders have an 
increased risk of developing other comorbid mental 
disorders that can negatively impact academic 
performance and achievement later in life (12-14). 
Anxiety disorders in children and adolescents, if left 
untreated, can therefore result in a plethora of 
sequelae as its complications (15, 16).  
Exposure to a natural disaster can pose mental 
health challenges in children (17). Research has 
consistently shown a positive correlation between 
anxiety disorders in children and exposure to natural 
disasters (18, 19). Children and adolescents who 
experienced disasters might suffer from greater stress 
because of the lack of development of the required 
emotional reactions and coping strategies (20). 
However, research evidence is scanty when it comes 
to the effects of a pandemic on anxiety disorders, 
particularly in children. This group among the 
general population deserves special attention, as it is 
particularly vulnerable to the psychological effects of 
the pandemic. The severity of symptoms of the 
disease in most children, fortunately, has been rather 
mild though, with death being an extremely rare 
outcome (19). However, this is not an indication that 
children have been affected less than any other age 
group as they continue to be vulnerable to the 
significant negative outcomes of the pandemic’s 
unprecedented societal and economic disruption 
(21). The long period of separation from the usual 
outside world, excessive worries of being infected, 
and the impact of the multi-channel negative 
information have all resulted in people experiencing 
fear, loneliness, panic, anxiety, and depression amid 
the coronavirus outbreak (22, 23). It is anticipated 
that this unprecedented disruption to children’s lives 
may precipitate the development of anxiety and 
depressive disorders in children (24).  
Disease-containment measures such as quarantine 
and isolation can adversely affect the mental health 
of children and adolescents significantly (25). 
Children quarantined with suspected or diagnosed 
COVID-19 infection are likely to develop acute 
stress, anxiety, and adjustment disorders (26). 
Previous studies have also demonstrated that 
quarantine can have a long-term adverse 
psychological impact on children (27). The 
consequences of COVID-19 on children, both 
immediate and long-term, are therefore vast in terms 
of their health, safety, and wellbeing. A preliminary 
study conducted in the Shaanxi province during the 
COVID-19 epidemic by the China-EPA-UNEPSA 
collaborative working group showed that clinging, 
inattention, and irritability were the most severe 
psychological conditions demonstrated by the 
children in all age groups (28) A nationwide 
longitudinal survey conducted in two waves during 
the COVID-19 pandemic concluded that up to 
30.1% of 11-17 years old had symptoms of 
generalized anxiety compared to 14.9% prior to the 
pandemic (29). Moreover, a recent meta-analysis 
found a pooled prevalence estimate of clinically 
elevated anxiety symptoms obtained during the first 
year of the COVID-19 pandemic to be around 
20.5%, almost double the pre-pandemic estimate (30) 
The impact of the COVID-19 pandemic on 
children’s lives in the state of Qatar has been no 
different than the rest of the world. The population 
of Qatar was estimated to be around 2.7 million in 
September 2020 out of which 14.4% (393K) were 
aged 0-14 years (31). The state took several 
immediate and effective measures at the outset to 
reduce the spread of the deadly virus some of which 
have continued throughout the pandemic with 
variable extent, depending on the number of daily 
new cases These measures included closures of 
schools, parks, and leisure centers, quarantining 
individuals and families in their homes or dedicated 
institutional quarantine centers, where appropriate, 
and implementing several other strategies to ensure 
social distancing. The quarantine process involved 
placing children with covid-19 in designated facilities 
to limit the infection from spreading further. 
Furthermore, these children did not require acute 
medical care and were accompanied by at least one 
parent/guardian during their stay at the quarantine 
facility. They had access to on-site medical support if 
required. 
This study aimed to determine the rates of elevated 
levels of overall anxiety as well as specific anxiety 
disorders in children in quarantine with COVID-19 
infection. Furthermore, it explored any differences in 
terms of age, gender, and residency status. It also 
aimed to provide further insights into the 
psychological support that may be required for 
children with confirmed COVID-19 infection who 
report elevated anxiety symptoms and, therefore, 
indicating a propensity to develop an anxiety 
disorder. This study is the first of its kind as there is 
no similar previous published work at the time of 
writing of this manuscript.  
 






Design and participants 
This questionnaire-based cross-sectional study was 
conducted during the spread of COVID-19 infection 
in the state of Qatar. The two dedicated, institutional 
pediatric COVID-19 quarantine centers under the 
auspices of Hamad Medical Corporation, the main 
public health care provider in Qatar, formed the two 
main sites of the study. 
All one hundred and forty-nine children aged 7-13 
years who were admitted to the two quarantine 
centers between 18th June to 16th July 2020 with a 
confirmed diagnosis of COVID-19 were assessed for 
eligibility to participate in the study. Children with a 
previous diagnosis of a mental or behavioral 
disorder, intellectual disability greater than mild, 
those who were critically unwell or who were not 
fluent in English or Arabic languages were excluded 
from the study. A total of 88 children and their 
parents agreed to participate in the study and also 
met the eligibility criteria as outlined above. Out of 
the sixty-one children who were excluded from the 
study, fifty-seven chose not to participate and the 
remaining four reported an established history of 
mental or neurodevelopmental disorders as 
mentioned in the exclusion criteria. It is worthy to 
mention that the excluded group was not 
overrepresented in terms of gender, age or residential 
status compared to the included group thereby 
mitigating the risk of selection bias. 
 
Ethical considerations and data collection 
The study received prior approval from the Medical 
Research Center (MRC-05-036) and the Institutional 
Review Board (IRB) of Hamad Medical Corporation, 
Qatar. The study investigators present on the 
quarantine sites made phone contact with the parents 
of all children included in the sample to invite their 
children to participate in the study voluntarily. All 
information relevant to the study including its 
purpose, impact on clinical care and confidentiality 
safeguards, was provided to the parents and their 
participating children using an invitation form with a 
standard script developed specifically for the study, 
in both English and Arabic languages.  
Informed, written parental consent and child’s 
assent (where applicable) were obtained. The web 
link of the online questionnaire including 
consent/assent confirmation was securely 
communicated by the study investigators deployed at 
the two quarantine centers to the parents of the 
participating children. The usage of paper and face-
to-face contact was avoided to mitigate the spread of 
infection. Data collection was completed during July 
2020. All completed responses were received online.  
 
Measures 
We used the original English version as well as a 
previously validated Arabic version of the Child-
reported Spence Children’s Anxiety Scale (32, 33). 
The Spence Children’s Anxiety Scale (SCAS) was 
developed to assess the severity of anxiety symptoms 
broadly in line with the dimensions of anxiety 
disorder proposed by the DSM-IV (34, 35). The scale 
assesses six domains of anxiety namely generalized 
anxiety, panic/agoraphobia, social phobia, 
separation anxiety, obsessive-compulsive disorder, 
and physical injury fears. SCAS is also used to screen 
children at risk for the emergence of anxiety 
disorders secondary to elevated anxiety symptoms 
(36). Moreover, it is considered a reliable instrument 
for cross-cultural use (37). 
It is designed to be relatively easy and quick for 
children to complete, normally taking only around 10 
minutes to answer the questions. It consists of a total 
of 44 items, of which 38 relate to specific symptoms 
of anxiety and 6 are positive, filler items to mitigate 
negative response bias. Of the 38 anxiety items, 6 
reflect separation anxiety, 6 social phobia, 6 
obsessive-compulsive problems, 6 panic/3 
agoraphobia, 6 generalized anxiety/overanxious 
symptoms, and 5 items relate to fears of physical 
injury. Items related to specific anxiety disorders are 
allocated randomly within the questionnaire. 
Children are asked to rate the frequency of each 
symptom on a 4-point scale involving never (0), 
sometimes (1), often (2), and always (3).  
The SCAS has now been used in a significant 
number of research studies to measure symptoms of 
anxiety. It has been evaluated in community and 
clinical samples of children and young people with 
evidence to support their internal consistency, test-
retest reliability, convergent and divergent validity, 
and ability to distinguish between children with 
anxiety disorders versus community samples (38-40). 
Its test-retest reliability has also been found to be 
high for overall anxiety as well as symptoms of 
specific anxiety disorders (35). In addition to 
normative data, T-Scores have been developed to 
establish whether anxiety symptoms are elevated 
above what would be regarded as normal levels in 
equivalent age and gender groups within the 
community. They are standardized scores calculated 
from the total distribution of scores within the 
community sample. The cut-off points for elevated 
levels of anxiety are established using age-range and 
gender-specific T-scores. Raw total scores for overall 
anxiety and specific anxiety disorders obtained after 
adding responses on the scale are considered in 
elevated range if their equivalent T-scores are above 
60. 
 






The Statistical Package for the Social Sciences (SPSS) 
version 25 was used to carry out statistical analysis. A 
two-tailed p-value of ≤0.05 was considered for 
statistical significance. The results of a descriptive 
analysis were presented as frequency and percentage. 
A student t-test was utilized to analyze continuous 
data. The results were presented as mean ± SD. A 
chi-square test was used to analyze categorical values. 




The sample of this study consisted of 88 COVID-19 
positive children admitted to institutional quarantine 
centers. The results were compiled in a manner to 
allow for investigators to look at all 88 participants as 
a single group for common findings as well as break 
the data down into sub-groups based on age (7-11 
years and 12-13 years), gender, and residency status 
(expatriates/natives) in line with the objectives of the 
study. The age-ranges used to form two groups for 
compilation of results were consistent with the age 
requirement for cut-off scores on the Spence 
Children’s Anxiety Scale (SCAS). Moreover, they 
drew a reasonable distinction between younger and 
older children. The 7-11 years group had 64 
participants (72.7%), and the 12-13 years group had 
24 participants (27.3%). The majority of participants 
were males, n=48 (54.5%), and expats, n=64 
(72.7%). See Table 1.  
A total of 36.3% (n=32) of the study sample met 
the respective elevated cut-off score for overall 
anxiety disorder. Among males, 37.8% (n=14) of the 
7-11 years age group and 63.6% (n=7) of the 12-13 
years age group had an elevated score for overall 
anxiety disorder above the assigned cutoff for each 
group (total score ≥ 40 and  ≥ 33, respectively), 
p=0.13. Among females, 25.9% (n=7) of the 7-11 
years age group and 30.8% (n=4) of the 12-13 years 
age group had an elevated score above the assigned 
cutoff for each group (total score ≥ 50 and ≥ 40, 
respectively), p=0.74. The percentages of the study 
sample that met the various criteria for total score 
and subscale scores are outlined in table 2 below.  
The largest group among the 88 children reported 
elevated levels of physical injury fears, n=62 (70.4%), 
followed by Separation anxiety, n=51 (57.9%), 
Obsessive-Compulsive disorder, n=28 (31.8%), 
Social Phobia, n=21 (23.8%), Generalized Anxiety 
Disorder, n=19 (21.5%) and panic/agoraphobia, 
n=17 (19.3%). See Table 2.  
The mean score for overall anxiety disorder was 
36.7 ± 15.7 on the Spence Children’s Anxiety Scale. 
The following are the mean scores on each of the 
sub-scales: generalized anxiety 5.7 ± 3.4, obsessive-
compulsive 6.7 ± 3.8, physical injury fears 6.7 ± 3.2, 
social phobia 5.7 ± 3.7, panic/agoraphobia 3.9 ± 3.8, 
and separation anxiety 7.7 ± 4.0. 
Among the gender groups, elevated scores for 
overall anxiety disorder were reported more 
frequently in males, n=21 (43.75%) as compared to 
females, 11 (27.5%) (Table 2). There were no 
significant differences in the mean scores of anxiety 
levels between males and females. Table 3 reports the 
mean ±SD among gender groups on each subscale.   
When comparing natives to expats, elevated levels 
for overall anxiety disorder were reported more 
frequently in expats, n=26 (40.6%) compared to 
natives, n=6 (25%) (Table 4). No significant 
differences were reported between the mean scores 
of the two groups except for the OCD sub-scale 
(p=0.03). Table 4 below shows further comparisons 
between the two groups.  
When comparing the two age groups included in 
this study, elevated symptoms of overall anxiety were 
reported by 32.8% of younger children (7-11 years) 
compared to 45.8% of older children (12-13 years). 
There was no significant statistical difference found 
between the mean scores of these two age groups 
though. Table 5 shows further comparisons between 
the two age groups.  
 
Discussion 
This study, to our knowledge, is the first of its kind 
to explore the prevalence rates of anxiety disorders 
in children with COVID-19 infection. It is also 
unique in that it compares the severity of anxiety 
symptoms between the native and expatriate 
populations.  
This study found high prevalence rates of anxiety 
disorders among children with COVID-19 infection 
under quarantine. As many as 36.3 % of the children 
reported elevated levels of overall anxiety. This rate 
is higher than reported in children in the general 
population both before and during the pandemic. A 
cross-sectional study conducted in China (n=2330) 
during the pandemic among children with an age 
range similar to our sample found a rate of 18.9% for 
anxiety disorders (41). This rate, as may be observed, 
is almost half of that reported in our study.  
A recent systematic review suggested that 
quarantine is associated with far reaching and 
significant negative impact on psychological 
wellbeing of children and adolescents (42). Another 
recent study involving 1143 parents of Italian and 
Spanish children aged 3 to 18 years showed that 
85.7% of the parents perceived changes in their 
children’s emotional state and behaviors during 
COVID-19 quarantine. Boredom, irritability, 
restlessness, nervousness, feelings of loneliness, and 
being more uneasy and more worried were reported 







TABLE 1. Sample’s demographics 
 Male (n=48) P-value Female (n=40) P-value 
Natives Expats  Natives Expats  
7-11 years 11 (29.7%) 26 (70.3%)  0.44 8 (29.6%) 19 (70.4%)  0.66 




TABLE 2. Elevated overall anxiety and sub-scale scores on the Spence Children’s Anxiety Scale 

























Total Score ≥40 3(27%) 11(42%) ≥33 0 7(77%) ≥50 2(25%) 5(26%) ≥40 1(33%) 3(30%) 
Generalized anxiety ≥8 3(27%) 5(19%) ≥7 0 3(33%) ≥10 3(37%) 3(15%) ≥9 1(33%) 1(10%) 
Obsessive-Compulsive ≥9 1(9%) 8(30%) ≥7 0 6(66%) ≥10 1(12%) 5(26%) ≥7 2(66%) 5(50%) 
Physical injury fears ≥5 8(72%) 17(65%) ≥4 0 8(88%) ≥6 5(62%) 13(68%) ≥6 3(100%) 8(80%) 
Social phobia ≥8 2(18%) 5(19%) ≥8 0 6(66%) ≥10 2(25%) 4(21%) ≥10 0 2(20%) 
Panic/agoraphobia ≥7 1(9%) 6(23%) ≥4 0 5(55%) ≥9 3(37%) 1(.05%) ≥7 0 1(10%) 





TABLE 3. Mean overall anxiety and subscale scores (gender) 
 Male (n=48)  Female (n=40) P-value 
 Mean ± (SD)  
Total score  35.4 ± (15.3) 38.2 ± (16.1) 0.41 
Generalized anxiety 5.5 ± (3.1) 6.0 ± (3.7) 0.47 
Obsessive-Compulsive 6.2 ± (3.6) 7.4 ± (4.1) 0.15 
Physical injury fears 6.6 ± (3.5) 6.8 ± (3.0) 0.74 
Social phobia 5.2 ± (3.5) 6.3 ± (4.02) 0.18 
Panic/agoraphobia 3.9 ± (3.8) 4.0 ± (3.9) 0.85 







TABLE 4. Mean overall anxiety and subscale scores (natives vs expatriates) 
 Natives (n=24) Expats (n=64) P-value 
 Mean ± (SD)  
Total score  34.5 ± (17.7) 37.5 ± (14.9) 0.42 
Generalized anxiety 6.1 ± (4.3) 5.5 ± (3.0) 0.58 
Obsessive-Compulsive 5.3 ± (3.1) 7.2 ± (4.0) 0.03 
Physical injury fears 6.3 ± (3.0) 6.8 ± (3.3) 0.51 
Social phobia 5.3 ± (3.4) 5.8 ± (3.9) 0.54 
Panic/agoraphobia 4.1 ± (4.4) 3.9 ± (3.6) 0.79 




TABLE 5. Mean overall anxiety and subscale scores (age) 
 Age 7-11 group (n=64) Age 12-13 group (n=24) P-value 
 Mean ± (SD)  
Total score  36.9 ± (16.2) 35.9 ± (14.5) 0.78 
Generalized anxiety 5.8 ± (3.6) 5.3 ± (2.8) 0.49 
Obsessive- Compulsive 6.5 ± (3.9) 7.2 ± (3.6) 0.48 
Physical injury fears 6.9 ± (3.4) 6.2 ± (2.7) 0.34 
Social phobia 5.3 ± (3.6) 6.6 ± (3.9) 0.15 
Panic/agoraphobia 3.9 ± (4.0) 4.0 ± (3.4) 0.98 




Furthermore, a systematic review and meta-analysis 
examining the pooled prevalence of anxiety and 
other mental disorders s among children and 
adolescents during global COVID-19 pandemic in 
2019 to 2020 reported a rate of 26% for anxiety 
disorders (44) 
Several factors may explain the high prevalence 
rates of elevated anxiety symptoms reported in our 
study. These may include staying away from the 
home environment in a quarantine center, worrying 
and uncertainty related to the outcome of disease, 
and the impact of disease symptoms. 
The prevalence of anxiety disorders tends to 
increase with age in children and adolescents (45). A 
nationally representative survey of adolescents (age 
13-18 years) in the US, reported the lifetime 
prevalence of anxiety as high as 31.9% (46). In our 
sample, 32.8% younger children (7-11 years) 
compared to 45.8% older children (12-13 years) 
reported elevated levels of symptoms of overall 
anxiety. A similar trend has been found in children 
with no COVID-19 infection during the pandemic. 
A large cross-sectional study in China (n=8079) was 
conducted in March 2020 and found anxiety 
prevalence to be 37.4 % in older adolescents (12-18 
years) without COVID-19 infection (47).   
The difference in the prevalence of elevated 
anxiety symptoms between younger children and 
older adolescents as reflected in our study is 
consistent with previous research. However, it may 
be surmised that older children may report higher 
anxiety rates because of their greater understanding 
of the situation and associated uncertainty. In other 
words, the differences in these age groups may be 
further accentuated since older children and 
adolescents can better conceptualize the COVID-19 
situation.  
Our study also revealed alarmingly high rates 
(70.4%) of elevated symptoms of physical injury fears 
elicited by things and events commonly considered 
the objects of specific phobias. This rate is several 
times higher than what has been reported previously. 
The 1-year prevalence of specific phobia in children 
and adolescents has been reported previously as 
7.9% (48). In a Dutch study of 13-18 years old 
adolescents, the prevalence rate for self-reported 
specific phobias was found to be 4.5% (49).  
Similarly, the rates of elevated levels of separation 
anxiety symptoms reported in this study (57.9%) 
were much higher than reported previously (50, 51). 
Furthermore, the higher mean score of separation 
anxiety reported in this study among younger 
children (7-11 years) compared to their older 
counterparts (12 and 13 years) is consistent with the 
previously held view that symptoms of separation 
anxiety are more elevated in younger children. It is 
pertinent to mention that children were quarantined 
with at least one parent or guardian after obtaining 
the required permissions. The proximity with usual 
caregivers may have allowed children more flexibility 
with adapting to their environment. This may have 
mitigated slightly the rates of elevated anxiety 
symptoms reported in our study, particularly those of 
separation anxiety.  
It is well-established that the migrant population is 
more susceptible to stress (52) and mental health 
issues among them pose a public health challenge 




study as a higher prevalence rate of overall anxiety 
was reported in children from expat families (40.6%) 
compared to native children (25%).  
The difference in the mean scores between the 
expat and native group of children was found 
statistically significant for obsessive-compulsive 
symptoms. Although the possibility of the 
differences in the OCD-symptom scores between 
the two groups may have been influenced by 
differences in their attitudes to conform to COVID-
19 guidance, individuals engaging in such behaviors 
may still be indicative of the likelihood of underlying 
obsessionality. It has been established through 
previous research that obsessive-compulsive 
disorder is particularly relevant to pandemic worrying 
and is most significant in this context (54, 55). Fear 
of contamination and washing compulsions are 
among the core symptom dimensions of OCD (56). 
In previous outbreaks such as SARS and H1N1 
influenza, obsessive-compulsive beliefs and 
symptoms worsened and predicted fears related to 
the infection (57, 58). 
The findings from our study highlight the global 
need to focus on the psychological health of young 
children and adolescents with COVID-19 infection.  
A multitude of factors may have contributed to the 
increased anxiety levels in these children. Worrying 
about possible complications from the infection, the 
fear of spreading the infection to family and friends, 
and the curtailment of social functioning due to 
quarantine may all have played their role. As part of 
its robust COVID-19 response, Qatar has 
fortunately made several psychological services 
available including around-the-clock telephone 
helplines, outpatient and inpatient services as well as 
virtual consultations. Providing mental health 
support to young children and adolescents in general 
and those who contract the COVID-19 infection in 
particular is an important aspect of mitigating the 
impact of the pandemic. 
This includes the need for effective screening and 
prompt identification of clinical features of emerging 
mental disorders and providing appropriate early 
interventions. Such an approach, if adopted globally, 
has the potential to mitigate the mental health burden 
associated with COVID-19. On the other hand, if the 
mental health complications associated with the 
pandemic are not addressed effectively, it has the 
potential to cause a global crisis of epic proportions.  
Future follow-up studies exploring anxiety 
symptoms at a different time of the pandemic may 
help clarify whether the severity of anxiety varies 
with the time and setting. There is a possibility that 
the fears related to the illness may be allayed with 
better understanding of the illness, its prevention and 
management. Furthermore, future studies focusing 
on anxiety symptoms in children who have not 
contracted the infection may help with drawing a 
distinction between the impact of the stress or stigma 




Children subjected to institutional quarantine due to 
COVID-19 infection may be at risk of developing 
anxiety disorders. Expatriate children are more likely 
to report elevated levels of anxiety disorder than their 
native counterparts suggesting that this group of 
children and their families may be particularly 
vulnerable to the psychological impact of the 
COVID-19 pandemic. The governments and 
organizations across the globe need to ensure the 
availability of the required resources and services so 
that the mental health needs of children during the 
pandemic are identified and addressed promptly and 
effectively.  
 
Limitations and strengths 
One limitation of our study could be its relatively 
small sample size. The cross-sectional design also did 
not allow for follow up to measure any changes in 
symptoms over time. A follow-up study exploring 
whether children with elevated anxiety symptoms go 
on to develop anxiety disorders and require input 
from mental health services, may prove helpful. The 
strengths of the study include use of a recognized and 
validated scale (SCAS) and its uniqueness in that no 
previous study has looked at the prevalence rates of 
anxiety disorders among children in quarantine with 
confirmed COVID-19 infection. The findings of the 
study are crucial for future healthcare planning in 
relation to early identification and management of 
mental disorders in children.   
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